Excerpts

At the CD4SP stage, we found barely significant NCE enhancer function in the murine EL-4 CD4SP lymphoma cell line with the NCE1F, but not with the NCE1Fx2, even though the proximal enhancer was still functional ( Figure 2C ), indicating that NCE’s canonical enhancer function may diminish in mature CD4SP T cells.

The IVIG group showed a trend toward better Barthel Index scores without statistical significance.

Notably, the same study revealed an increase in B lymphocytes, but statistical analysis was marginally non-significant ( 139 ).

Subsequently, the average number of citations showed a trend of increasing and then decreasing, with the total number of citations peaking in 2018, reflecting a very active year in the field.

With regard to a potential effect of PD-1 blockade on the CXCR3/CXCL9 axis, we found that macrophages from tumors of GPR55 KO mice expressed significantly more CXCL9 than those from tumors of their WT counterparts, while noticing a strong trend in the same direction for monocytes ( Figure 6F ).

Overall, Figure 10C predominantly shows positive difference multiples, indicating an increasing trend, whereas Figure 10D mostly displays negative difference multiples, suggesting a decreasing trend.

The differential abundance score (DA score) calculations indicated a positive trend for all metabolites in these pathways ( Figure 10G ), whereas in the B. animalis BD400 group, metabolites in each pathway exhibited a decreasing trend ( Figure 10H ).

Both neutrophils and protein leakage showed a trend suggesting increased inflammation with the loss of B cells ( Figures 6D, E ).

Figure 1D displays the mean CD3-positive cell dose infused per DLI for each case, with the doses showing a decreasing trend over the years.

DPP4 and PARP11 revealed the decreasing tendency in malignant samples, with approximately significant P values ( Supplementary Figure S5C ).

The findings suggested that while PD-L1 inhibitors combined with CT showed a trend toward OS improvement, this did not achieve statistical significance (HR = 0.829, 95% CI: 0.683-1.006; 95% PI: 0.236-2.916, I 2 = 0%) ( Table 2 ; Supplementary Figure 11A ).

However, a post-hoc analysis of both trials suggested a clear trend toward benefit as blood eosinophil counts increased ( 54 ).

For short-term poor prognosis, multivariate logistic regression showed that elevated TyG index was an independent risk factor, with a borderline significant P value of 0.068.

TyG quartile-stratified GBS patient characteristics are presented in Table 4 , with a notable trend of increasing age in patients with higher TyG index.

Although the changes in glud1 and glul expression were not statistically significant but showed a decreasing trend, suggesting partial amelioration of the nitrogen metabolism disorder by the ZO-1 agonist. 3.4 The ZO-1 agonist is associated with preservation of TJ protein complex organization GSEA ( Figures 5A–C ) revealed that the TJ pathway (KO04530) was significantly upregulated in the Control vs.

Mepolizumab significantly improved nasal obstruction VAS score from baseline to weeks 49–52 compared with placebo, with a mean treatment difference of −1.43, and showed a numerical trend toward improvement in total endoscopic nasal polyp score at week 52, with a mean treatment difference of −0.43 ( 107 ).

MR analysis confirmed that downregulation of PRR4 expression is a risk factor for CRSwNP (OR = 0.99951, P = 0.04280), with the caveat that the very small effect size and borderline significance indicate limited evidence strength at present.

MR analysis preliminarily suggested that IL4R and IMPA2 may be potential risk factors for CRSwNP, while PRR4 may serve as a potential protective factor, though the effect sizes were modest (OR values close to 1) and P values were borderline significant (0.043–0.045), indicating limited evidence strength.

Although between-regimen differences were not statistically significant, mepolizumab 300 mg showed a numerical trend toward earlier glucocorticoid sparing (e.g., higher GC-free rates and fewer patients on higher GC doses at intermediate visits), which may reflect its preferential use in patients with systemic disease and its intended role in systemic disease management ( 6 , 7 ).

In contrast, good responders' patients showed significant reductions in TM, ANG2, sC5b9, and a decreasing trend in VWF : Ag and VWF activity, supporting a recovery of endothelial stability following ECP.

Colonic length was significantly shortened in adult mice of the model group (p < 0.0001), whereas colonic length in the model + CEH group showed a trend toward recovery, although the difference did not reach statistical significance ( Figures 1F, G ). 3.2 Casein hydrolysate preserves intestinal mucosal architecture and goblet cell integrity At the histological level, PAS staining of the ileum showed that the number of goblet cells in the crypt region was markedly lower in the model group than in the control group, indicating damage to the mucus-secreting barrier ( Figure 2A ).

IgG antibodies reacting with AoC protein extracts were detected at both 14 and 35 days after AoC treatment alone or in the presence of OVA/alum, showing an increasing trend over time ( Figures 6B, C ).

In resident DCs, a decreasing trend was also observed at both 1–2 days post-injection, with no significant difference compared to PBS; a significant decrease was detected at 4 days post-injection ( Supplementary Figures 5A, B ).

Although the frequency of CX3CR1 neg cells showed only a modest upward trend, cell number analysis revealed a significant expansion of the CX3CR1 neg population, with CX3CR1 int cells also exhibiting an increasing trend and CX3CR1 hi cells maintained at comparable levels under anti-PD-L1 antibody treatment ( Supplementary Figure 9C ).

Modern approaches illustrate an important trend toward integrated design and enhancement strategies that simultaneously optimize affinity, stability, and immunogenicity risk preserving developability attributes.